{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/immunizations-pneumococcal/background-information/prevalence-of-pneumococcal-disease/","result":{"pageContext":{"chapter":{"id":"aba9a3c5-f0f7-5e65-b369-1947461d0158","slug":"prevalence-of-pneumococcal-disease","fullItemName":"Prevalence of pneumococcal disease","depth":2,"htmlHeader":"<!-- begin field 5ebbc12c-a330-47a8-b681-5d7ed27199d7 --><h2>Prevalence of pneumococcal disease</h2><!-- end field 5ebbc12c-a330-47a8-b681-5d7ed27199d7 -->","summary":"","htmlStringContent":"<!-- begin item fa33a3ec-1f28-4343-8f4d-152b9e002f08 --><!-- begin field 97a3bfe1-6007-42ca-bc15-a67337f4587d --><ul><li><strong>Non-invasive pneumococcal disease in adults mainly causes community-acquired pneumonia </strong>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-pneumococcal/references/\">Drijkoningen and Rohde, 2014</a>]<strong>. </strong><ul><li>Community-acquired pneumonia affects around 1 in every 1,000 adults each year, with a case fatality ratio of 10–20% [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-pneumococcal/references/\">PHE, 2013a</a>].</li></ul></li><li><strong>Annually, Public Health England receives reports of over 5,000 cases of invasive pneumococcal disease (IPD), </strong>with isolates from blood, cerebrospinal fluid, or other normally sterile sites [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-pneumococcal/references/\">PHE, 2013a</a>].<ul><li>During 2009–2011, the incidence of IPD in children aged 5–15 years in the UK was 2.2/100,000 [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-pneumococcal/references/\">Ladhani et al, 2014</a>].</li></ul></li><li><strong>A study of the incidence of pneumococcal meningitis in England</strong> between 1995 and 2005 using hospital episode statistics found [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-pneumococcal/references/\">Johnson et al, 2007</a>]:<ul><li>An annual incidence rate of about 1 case per 100,000 population.</li><li>The disease was most common in children aged 5 years and under, with the highest incidence in children aged 2–11 months.</li></ul></li><li>Since the introduction of the pneumococcal conjugate vaccine (Prevenar<sup>®</sup>), the number of cases of IPD caused by the seven serotypes contained in the vaccine fell by 50% [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-pneumococcal/references/\">PHE, 2013a</a>].</li></ul><!-- end field 97a3bfe1-6007-42ca-bc15-a67337f4587d --><!-- end item fa33a3ec-1f28-4343-8f4d-152b9e002f08 -->","topic":{"id":"af89c4a4-b7c5-5032-9cab-157c542f213b","topicId":"667146c4-e374-494f-a050-b8976e5e7056","topicName":"Immunizations - pneumococcal","slug":"immunizations-pneumococcal","lastRevised":"Last revised in January 2021","chapters":[{"id":"c2a8d969-5d35-5185-b666-883786b066c5","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"9db009c1-59ed-5d79-9446-33e54e1676c7","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"cf4adec7-88ef-5a0f-b072-53bd3049b260","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"5459dd7c-ac40-5828-8bec-840fa7fca764","slug":"changes","fullItemName":"Changes"},{"id":"197178ce-11cd-52df-883c-419e06744dd4","slug":"update","fullItemName":"Update"}]},{"id":"95a44f6b-2987-5086-8656-ef21fcbbc28b","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"006db835-5d01-5085-a6e1-ee57f7ca41c8","slug":"goals","fullItemName":"Goals"},{"id":"29af8dc8-13e9-56c4-a041-b00bbf320b1e","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"e7b32647-3434-5f3f-b8be-51203e3ebfee","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"ebc71bdc-4766-5946-bb16-121b9da544f3","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"3daf6a12-bce0-53d4-a318-05cc49aab107","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"4dce4bc5-1119-5c5d-9422-d275fc956a4e","slug":"nice-quality-standards","fullItemName":"NICE Quality standards"}]},{"id":"002fbb60-3041-597d-9d3d-fc3a17068591","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"37c59838-49d0-51d5-8203-1eae848738c2","slug":"definition-of-pneumococcal-disease","fullItemName":"Definition of pneumococcal disease"},{"id":"aba9a3c5-f0f7-5e65-b369-1947461d0158","slug":"prevalence-of-pneumococcal-disease","fullItemName":"Prevalence of pneumococcal disease"},{"id":"9da9e662-ccc4-5bc4-bae8-eb3f0ec80b19","slug":"risk-factors-for-pneumococcal-disease","fullItemName":"Risk Factors for pneumococcal disease"},{"id":"492f20c5-5e03-51dc-9ccb-1994f3db1c35","slug":"pneumococcal-immunization","fullItemName":"Pneumococcal immunization"}]},{"id":"e183f01f-d538-542b-bc16-6f849966d1d2","fullItemName":"Management","slug":"management","subChapters":[{"id":"b036915e-0e64-5fea-a247-9777822304b3","slug":"routine-vaccination-of-infants-adults-over-65-years-of-age","fullItemName":"Scenario: Routine vaccination of infants, and adults over 65 years of age"},{"id":"8f83b7e0-d764-5bca-a03b-e549e24f402a","slug":"children-diagnosed-at-increased-risk-under-2-years-of-age","fullItemName":"Scenario: Children diagnosed at increased risk under 2 years of age"},{"id":"c9787edf-835f-54d9-9b86-b7c8695307ef","slug":"children-diagnosed-at-increased-risk-aged-2-5-years","fullItemName":"Scenario: Children diagnosed at increased risk aged 2-5 years"},{"id":"7f443a07-5081-5296-b56e-8b82550f8c52","slug":"children-over-5-years-of-age-adults-diagnosed-at-increased-risk","fullItemName":"Scenario: Children over 5 years of age and adults diagnosed at increased risk"}]},{"id":"f17e101b-7bea-59aa-9b9c-46924bbfdc2b","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"871f5861-588e-57ef-9521-0a81e77d4583","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"d0a50959-6448-5a18-8845-f75f5c40f388","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"92b33782-e97b-565d-b432-b19376ecedbc","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"5b1e27f9-71f0-5238-978b-5648b601e292","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"2b6c5d09-7606-5742-89c4-19fa3b671fd7","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"037af05f-e510-5862-b316-4676f7c3a61e","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"04bd9328-ed11-5b9d-ba9a-06584ecd6f33","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"002fbb60-3041-597d-9d3d-fc3a17068591","slug":"background-information","fullItemName":"Background information"},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}